MicroPort NeuroScientific Corporation

As of December 31, 2025, MicroPort NeuroScientific Corporation carries a market capitalization of 6.35B, placing it among publicly traded companies globally. Its enterprise value stands at 5.23B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

MicroPort NeuroScientific Corporation's next confirmed earnings release is scheduled for March 31, 2027.

As of December 31, 2025, MicroPort NeuroScientific Corporation has 583.26M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, MicroPort NeuroScientific Corporation maintains a current ratio of 6.01, meaning it holds 6.0x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on August 31, 2026, MicroPort NeuroScientific Corporation's stock has declined approximately 38.32% over the past 52 weeks. The 50-day moving average sits at 9.24, while the 200-day moving average is 10.46.

As of December 31, 2025, MicroPort NeuroScientific Corporation holds 1.13B in cash and equivalents against 17.74M in total debt, resulting in a net debt position of -680.26M. Total book value stands at 2.00B, with working capital of 1.39B providing operational flexibility.